Spinal Infection Secondary to Mycobacterium branderi

Michael Drakopoulos, Nonye Ogbuefi, Shannon Galvin, Kendall Kling*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Mycobacterium branderi is a rare, slow-growing, nontuberculous mycobacterium initially identified as a species in 1995. Mycobacterium branderi has previously been reported as the sole pathogen isolated from pulmonary cavitary lesions and from a hand infection. We present a case of M. branderi as the sole pathogen isolated from a spinal epidural abscess associated with discitis, osteomyelitis, and psoas muscle abscesses in an immunocompromised host. The isolate was subjected to DNA hybridization testing and 16S rRNA gene sequencing, with results consistent with M. branderi and Mycobacterium celatum. Subsequent RNA polymerase β subunit gene sequencing identified the organism as M. branderi. The spinal infection is being treated with trimethoprim-sulfamethoxazole, ethambutol, azithromycin, and rifabutin. Repeat spinal cultures after initiation of treatment were negative for growth suggesting eradication of the organism.

Original languageEnglish (US)
Article numbere1193
JournalInfectious Diseases in Clinical Practice
Volume31
Issue number1
DOIs
StatePublished - Jan 1 2023

Keywords

  • drug susceptibility testing
  • immunocompromised
  • Mycobacterium branderi
  • nontuberculous mycobacterium
  • spinal abscess

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Spinal Infection Secondary to Mycobacterium branderi'. Together they form a unique fingerprint.

Cite this